BCSH Guidelines Flashcards
(124 cards)
VWD 2024
Initial panel of tests for VWD
FBC and film
PT, APTT, Clauss Fn
FVIII:C
VWF:Ag
VWF:Act (RCo, GP1bR, GP1bM)
Additional tests if Act:Ag <0.7
VWD 2024
Additional tests for VWD T2
FVIII:C (low —> T2N)
VWF:CB
Multimers
RIPA if T2B suspected
Genetics
VWF:FVIIIB only if genetics atypical
VWD 2024
Who gets DDAVP test
All but T2B and T3
VWD 2024
Diagnosis VWD T3
VWF:Ag <1 IU/dL
Confirmed by genetics
VWD 2024
Diagnosis VWD T1
VWF:Ag 1-30 IU/dL
VWF:Act 1-30 IU/dL
Act:Ag >0.7
Confirmed by genetics
VWD 2024
Diagnosis VWD T2N
VWF Act:Ag <0.7 (Ag might be normal)
FVIII:C <50
Sequence F8 gene and VWF
VWF:FVIIIB only if genetics atypical
VWD 2024
Diagnosis T2A
VWF:Ag >1 IU/dL
VWF:Act <30 IU/dL
Act:Ag <0.7
VWF:CB / VWF:Ag reduced
and/or
Multimers reduced
VWD 2024
Diagnosis T2M
VWF:Ag >1 IU/dL
VWF:Act <30 IU/dL
Act:Ag <0.7
VWF:CB / VWF:Ag normal
and/or
Multimers normal
VWD 2024
Diagnosis T2B
VWF:Ag >1 IU/dL
VWF:Act <30 IU/dL
Act:Ag <0.7
VWF:CB / VWF:Ag any
Genetics
and/or
RIPA - aggregation with low dose Ristocetin
Pre-procedure clotting 2024
How to assess bleeding risk pre-procedure
Not clotting screen/platelet count
Used structured questions eg HEMSTOP
Pre-procedure clotting 2024
In what circumstances do you do pre-op coag screen?
Procedure with a high risk of bleeding
And
Liver disease, malnutrition, antibiotics, risk of coagulopathy (e.g. sepsis/critical care)
Pre-procedure clotting 2024
Target Fn in unwell patients having procedure
> 1g/L
Pre-procedure clotting 2024
Threshold for platelet transfusion for tunnelled line
30
Pre-procedure clotting 2024
Threshold for TPO-RA in liver disease
<50 for high risk procedure
SMM 2024
Definition SMM
PP >30g/L (or BJP >500mg/day)
or
10-59% PCs in BM
and
No SLiM CRAB criteria
SMM 2024
SLiM CRAB criteria
S - >60% PCs in BM
Li - LC ratio >100
M - >1 MRI lesions >5mm
C - Hypercalcaemia
R - CrCl <40ml/min or creat >177
A - H <100
B - Lytic lesion >5mm
SMM 2024
When do renal biopsy
If using R criteria and SFLC <500mg/L
SMM 2024
3 tests to rule in/out amyloid
BNP
Trop
ACR
SMM 2024
IMWG risk SMM
Risk factors
PC >20%
PP >20g/L
SFLCr >20
CNA inc 14;14, 14;16, gain1q, -13/del13q
Low 0RF
Low-int 1RF
HIgh-int 2RF
High 3 RF
DBLCL 2024
Diagnostic workup DLBCL
Excision biopsy, or core if excision difficult
Sample analysed in SIHMDS and discuss in MDT
Baseline bloods inc LDH, HepB, HepC, HIV
PET-CT baseline or CT-NTAP if not possible
Contrast MRI brain if clinical suspicion CNS
Baseline ECG, consider echo
FISH for MYCr then BCL2 + BCL6 if positive
Determine COO
DLBCL 2024
IPI
Age >60
Stage III-IV
ECOG >1
LDH >ULN
>1 EN site
Out of 5
CNS-IPI
Same with extra point for kidneys/adrenal
DLBCL 2024
Primary prophylaxis
Aciclovir and septrin
Give all GCSF
DLBCL 2024
Supportive considerations for elderly
Bone health
Speciality referral e.g. cardiology
DLBCL 2024
1st line 18-60 Stage I/II, IPI 0, non-bulk
4x R-CHOP + 2x R